PG
50
5
JWN
65
-2
ADM
30
2
FE
44
3
AA
40
2
NFLX
62
-2
NWS
77
4
R
57
2
JNPR
45
3
TGNA
59
5
PX
48
2
HOG
36
5
BLK
55
-2
A
29
-12
PLD
46
6
MKC
35
5
ZTS
36
-2
NTRS
34
4
UNM
66
4
VRSN
48
-4
PG
50
5
JWN
65
-2
ADM
30
2
FE
44
3
AA
40
2
NFLX
62
-2
NWS
77
4
R
57
2
JNPR
45
3
TGNA
59
5
PX
48
2
HOG
36
5
BLK
55
-2
A
29
-12
PLD
46
6
MKC
35
5
ZTS
36
-2
NTRS
34
4
UNM
66
4
VRSN
48
-4
Financhill
Back

DexCom Quote, Financials, Valuation and Earnings

Buy
57

DXCM
DexCom

Last Price:
118.78
Seasonality Move:
17.6%

7 Day Trial

ALL ACCESS PASS

$ 7

DexCom Price Quote

$118.78
+0.38 (+0.32%)
(Updated: May 31, 2024 at 6:55 PM ET)

DexCom Key Stats

Buy
57
DexCom (DXCM) is a Buy
Day range:
$117.20 - $127.61
52-week range:
$74.75 - $142.00
Dividend yield:
0%
P/E ratio:
91.08
P/S ratio:
13.17
P/B ratio:
20.96%
Volume:
5.7M
Avg. volume:
2.6M
1-year change:
4.26%
Market cap:
$47.1B
Revenue:
$3.6B
EPS:
$1.55

How Much Does DexCom Make?

  • How Much Are DexCom's Sales Annually?
    DXCM Revenues are $3.6B
  • How Much Profit Does DexCom's Make A Year?
    DXCM net income is $541.5M

Is DexCom Growing As A Company?

  • What Is DexCom's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.24%
  • What Is DexCom's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 2%

DexCom Stock Price Performance

  • Did DexCom Stock Go Up Last Month?
    DexCom share price went down by -7.06% last month
  • Did DXCM's Share Price Rise Over The Last Year?
    DXCM share price rose by 4.26% over the past 1 year

What Is DexCom 52-Week High & Low?

  • What Is DexCom’s 52-Week High Share Price?
    DexCom has traded as high as $142.00 over the past 52 weeks
  • What Is DexCom’s 52-Week Low Share Price?
    DexCom has traded as low as $74.75 over the past 52 weeks

DexCom Price To Free Cash Flow

  • Is DexCom Stock Overvalued?
    DexCom is trading at a price to free cash flow ratio of 85.84
  • Is DexCom Stock Undervalued?
    DexCom EV to Free Cash Flow ratio is 79.91
  • What Is DexCom’s Price Earnings Growth Ratio?
    DXCM PEG ratio is 0.63
  • Is DexCom Trading At A Premium To Earnings?
    DexCom EV to EBIT ratio is 58.38

Is It Risky To Buy DexCom?

  • How Much Debt Does DexCom Have?
    Total long term debt quarterly is $2.4B
  • How Much Cash Does DexCom Have?
    Cash and short term investments quarterly total is $2.9B
  • What Is DexCom’s Book Value Per Share?
    Book value per share is 5.67

Is DexCom Cash Flow Positive?

  • What Is DXCM Cash Flow From Operations?
    Cash flow from operations (TTM) is $802.3M
  • What Is DexCom’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$325.1M
  • What Is DexCom’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$245.7M

DexCom Return On Invested Capital

  • Is Management Doing A Good Job?
    DXCM return on invested capital is 13.59%
  • What Is DexCom Return On Assets?
    ROA measures how assets are converting to revenues and is 10.09%
  • What Is DXCM Return On Equity?
    ROE is a measure of profitability and is 29.28%

DexCom Earnings Date & Stock Price

  • What Is DexCom's Stock Price Today?
    A single share of DXCM can be purchased today for 118.40
  • What Is DexCom’s Stock Symbol?
    DexCom trades on the nasdaq under the ticker symbol: DXCM
  • When Is DexCom’s Next Earnings Date?
    The next quarterly earnings date for DexCom is scheduled on July 26, 2024
  • When Is DXCM's next ex-dividend date?
    DexCom's next ex-dividend date is May 1, 2020
  • How To Buy DexCom Stock?
    You can buy DexCom shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

DexCom Competitors

  • Who Are DexCom's Competitors?
    Below is a list of companies who compete with DexCom or are related in some way:
    • Abbott Laboratories (ABT)
    • Align Technology Inc (ALGN)
    • Boston Scientific Corp (BSX)
    • Cardinal Health Inc (CAH)
    • Edwards Lifesciences Corp (EW)

DexCom Dividend Yield

Data Unavailable

DexCom Analyst Estimates

YoY Growth Past Surprise
EPS: 200% 18.61%
Revenue: 24.21% 1.11%

Analyst Recommendations

Buy Recommendations: 16
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 151.22
Upside from Last Price: 27.72%

Major Shareholders

  • How many DXCM shares are owned by institutional investors?
    598.4M DXCM shares are owned by institutional investors
  • How many DXCM shares are owned by insiders?
    2.7M DXCM shares are owned by insiders